Despite this, despite that. Tortured comparison.
They share some currency and interest rate sensitivities and little else apart from an industry grouping. RMD is actually down over 3 years despite a main competitor having a product recall. COH is simply a great company.
I wouldn't be comparing them in the rear view mirror over 12 months. Unless you're suggesting that RMD and COH share prices are also influenced by plasma pricing, a higher cost of blood arising from non-recessionary conditions in the US, RNA vaccine strategy and specific challenges embedding the VIFOR acquisition.
Despite this, despite that. Tortured comparison. They share some...
-
- There are more pages in this discussion • 4 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add CSL (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$308.93 |
Change
0.400(0.13%) |
Mkt cap ! $149.2B | |||
| Open | High | Low | Value | Volume |
| $310.56 | $311.00 | $308.84 | $113.8M | 367.5K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 150 | $308.89 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $308.94 | 120 | 1 |
View Market Depth
| Last trade - 16.10pm 12/08/2024 (20 minute delay) ? |
| CSL (ASX) Chart |